Resend / NextCell publishes its Year-End Report 2021/2022
NextCell Pharma AB (publ) (NXTCL or NextCell) publishes its Year-End Report for the period September 1, 2021 – August 31, 2022 The report is available on the company’s website: https://www.nextcellpharma.com/en/investors#financial-report. NextCells share is traded on Nasdaq First North Growth Market under the ticker "NXTCL". The amount in brackets refers to the corresponding period in the previous year.The complete report included.Fourth quarter (2022-06-01 until 2022-08-31) ● Operating income amounted to 1 405 (1 381) TSEK. ● Operating result amounted to -8 563 (-4 457) TSEK. ●